Kaisai Biotech announced that the net profit for the first quarter is expected to be 94 million yuan to 115 million yuan, an increase of 63.65% to 100.20% over the previous year. The sales volume and sales revenue of long-chain dibasic acid have risen sharply compared to the same period last year.
凯赛生物：预计一季度的净利润为9400万元至1.15亿元
Kaisai Biotech: Net profit for the first quarter is expected to be 94 million yuan to 115 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.